Drug intelligence / Profile preview

indiplon + sertraline

Development stage
Discontinued
Lead developer
Neurocrine Biosciences
Modality
Small Molecules
Administration
Oral
01

Overview

Indiplon + sertraline is a combination of two small-molecule drugs: **indiplon**, a nonbenzodiazepine hypnotic agent that is a selective GABA\(_A\) receptor agonist, and **sertraline**, a selective serotonin reuptake inhibitor (SSRI) primarily used as an antidepressant. Indiplon was investigated for the treatment of insomnia due to its high affinity for the GABA\(_A\) α1 receptor subunit, producing sedative effects with minimal evidence of tolerance or withdrawal[4][6]. Sertraline is widely used as an SSRI for major depressive disorder, various anxiety disorders, and other conditions. The combination of indiplon and sertraline has been specifically investigated in the context of insomnia co-occurring with depressive symptoms[8].

02

Targets

GABRA1 (Gamma-aminobutyric acid type A receptor alpha 1 subunit)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on indiplon + sertraline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on indiplon + sertraline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call